KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

AbCellera Biologics (ABCL) Cost of Revenue (2020 - 2025)

AbCellera Biologics filings provide 6 years of Cost of Revenue readings, the most recent being $2.9 million for Q3 2025.

  • Quarterly Cost of Revenue fell 7.3% to $2.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$878000.0 through Sep 2025, up 39.2% year-over-year, with the annual reading at $11.3 million for FY2022, 63.03% up from the prior year.
  • Cost of Revenue hit $2.9 million in Q3 2025 for AbCellera Biologics, down from $3.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $44.6 million in Q1 2022 and bottomed at -$53.6 million in Q4 2022.
  • Average Cost of Revenue over 5 years is $786000.0, with a median of $3.0 million recorded in 2025.
  • Peak annual rise in Cost of Revenue hit 1630.02% in 2022, while the deepest fall reached 3035.41% in 2022.
  • AbCellera Biologics' Cost of Revenue stood at $1.8 million in 2021, then tumbled by 3035.41% to -$53.6 million in 2022, then soared by 79.34% to -$11.1 million in 2023, then increased by 13.04% to -$9.6 million in 2024, then skyrocketed by 130.16% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Cost of Revenue are $2.9 million (Q3 2025), $3.0 million (Q2 2025), and $2.8 million (Q1 2025).